Stock MNOV MEDICINOVA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. MediciNova, Inc.

Equities

MNOV

US58468P2065

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
1.321 USD -1.45% Intraday chart for MediciNova, Inc. -4.99% -11.96%
May. 20 MediciNova, Inc. Receives Notice of Allowance for New Patent Covering MN-166 for the Prevention of Metastasis of Eye Cancer CI
May. 14 MediciNova, Inc. Receives Notice of Allowance for New Patent Covering MN-166 for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MediciNova Says Alcohol-Use Disorder Drug Reduced Rates of Heavy Drinking, Alcohol Craving in Mid-Stage Trial
MT
Maxim Group Adjusts MediciNova Price Target to $6 From $10, Maintains Buy Rating
MT
B. Riley Lowers MediciNova's Price Target to $6 from $11 After Revising Cost Capital Assumptions, Keeps Buy Rating
MT
MEDICINOVA : Maxim Starts MediciNova at Buy With $15 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MNOV Stock
  4. News MediciNova, Inc.
  5. Analyst Reco.